Apple AirPods Pro 3 vs Otofonix Groove

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid released in 2025, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $250, it sits in the most affordable price tier of OTC devices, though its overall sound performance ranks #49 of 65 in the category. This device delivers standout performance in music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect excellent stability without whistling or squealing during normal use. These strengths make the AirPods Pro 3 particularly appealing for users who prioritize media consumption alongside hearing assistance. However, speech clarity presents a more mixed picture. Speech in quiet scores 2.3/5, falling 0.53 points below the category average. Speech in noise measures 1.8/5, which is above the category average but still low in absolute terms. Own-voice comfort also trails at 1.9/5, sitting 0.61 points below typical OTC performance. The AirPods Pro 3 is best suited for users already invested in the Apple ecosystem who want hearing assistance combined with premium streaming quality. Those prioritizing speech understanding in conversations may want to explore alternatives like the Apple AirPods Pro 2, which scores higher overall at a lower listed price, or the Elehear Beyond at the top of this price range.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.